ArticleEuropean addiction research2018
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.
Article in European addiction research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06858527 (Adults With Attention Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment), which is not on this map. Cited by 61 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Adults With Attention Deficit Hyperactivity Disorder / Substance Use Disorder Comorbidity in Integrated Treatment: Effectiveness and Feasibility
Who cites it
61 citing papers in PubMed, 2 syntheses or guidelines pooled it, 170 citations in OpenAlex.
- Clinical Practice Guidelines for the Evaluation and Diagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A systematic review of the literature.Sultan Qaboos University medical journal · 2021Pooled it
- Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.Biological psychiatry · 2019Pooled it
- Attention-Deficit/Hyperactivity Disorder Treatment Patterns and Association With Clinical Outcomes in Adolescents and Young Adults with Co-Occurring Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Retrospective Analysis.Journal of the American Academy of Child and Adolescent Psychiatry · 2026Article
- Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms.The American journal on addictions · 2026Article
- Concurrent (Dual) Disorder Management Guidelines: Systematic Review Update.Journal of clinical medicine · 2026Review
- Mediating role of alcohol dependence in the associations between adult ADHD symptoms and a wide range of physical comorbidities.Scientific reports · 2026Article
- Discontinuation and reinitiation of pharmacological treatment for ADHD among individuals with ADHD and substance use disorder.BMJ mental health · 2026Article
- WADD-SEPD Consensus on Psychological Treatment of Dual Disorders II: Neurodevelopmental, Anxiety, Post-Traumatic Stress, Somatic Symptom, Eating, and Personality Disorders and Recommendations for Future Research.Journal of clinical medicine · 2026Review
- Urgent response is needed to address the stimulant-fentanyl related overdose crisis.Frontiers in psychiatry · 2026Article
- Self-Reported ADHD Diagnosis and Illicit Drug Use and Prescription Medication Misuse Among U.S. Working-Age Adults.Journal of attention disorders · 2025Article
- Trends of incident adult Attention-deficit/hyperactivity disorder diagnoses before, during and after the pandemic provincial state of emergency in British Columbia (2013-2023): a population-based study.Lancet regional health. Americas · 2025Article
- Prevalence of substance use disorder in individuals with attention deficit/hyperactivity disorder: associations with sex and psychiatric comorbidity.BMC psychiatry · 2025Article
- Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025Article
- ADHD, substance use disorders and stimulant treatment: understanding the relationships.World psychiatry : official journal of the World Psychiatric Association (WPA) · 2025Article
- Characterizing Prescription Stimulant Use in Adults with Overdose Involving Psychostimulants.Medical research archives · 2025Article
- Commentary on Young et al.: Clinical guidance is required for stimulant co-prescription with opioid agonist therapy.Addiction (Abingdon, England) · 2025Article
- ADHD and Alcohol Use Disorder: Optimizing Screening and Treatment in Co-occurring Conditions.CNS drugs · 2025Review
- The Use of Novel Stimulants in ADHD Self-Medication: A Mixed Methods Analysis.Brain sciences · 2025Article
- Transitioning From Pediatric to Adult Psychiatric Care for ADHD in Sweden: A Nationwide Study.Journal of attention disorders · 2025Observational
- Long-term changes on behavioral addictions symptoms among adults with attention deficit hyperactivity disorder treated with methylphenidate.Journal of behavioral addictions · 2024Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 10 institutions in 8 countries.
Funding
Abstract
Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended. Long-acting methylphenidate, extended-release amphetamines, and atomoxetine with up-titration to higher dosages may be considered in patients unresponsive to standard doses. This paper includes evidence- and consensus-based recommendations developed to provide guidance in the screening, diagnosis and treatment of patients with ADHD-SUD comorbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.